Used in pharmaceutical research as a key intermediate in the synthesis of bioactive molecules, particularly in the development of central nervous system agents. Its structure supports modulation of receptor activity, making it valuable in creating compounds with potential antidepressant, anxiolytic, or antipsychotic effects. The presence of the trifluoromethyl group enhances metabolic stability and lipophilicity, improving blood-brain barrier penetration. Also explored in medicinal chemistry for designing novel drug candidates targeting neurological disorders.